Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Hydrogel Microparticle‐Templated Anti‐Solvent Crystallization of Small‐Molecule Drugs

Hydrogel Microparticle‐Templated Anti‐Solvent Crystallization of Small‐Molecule Drugs

Thumbnail Image
Download
Name

Adv Healthcare Materials - 2021 - Bora - Hydrogel Microparticle‐Templated Anti‐Solvent Crystallization of Small‐Molecule.pdf

Description
Published version
Size

1.81 MB

Format

Adobe PDF

Checksum (MD5)

17f2342702c306fbf59df2b10ee1babd

sword-2025-02-28T21:46:30.original.xml (130 B)
Original SWORD entry document
Author(s)
Bora, Meghali
•
Hsu, Myat Noe
•
Khan, Saif A
•
Doyle, Patrick S
Date Issued
April 2022
Journal
Advanced Healthcare Materials
Publisher
Wiley
Citation
Bora, Meghali, Hsu, Myat Noe, Khan, Saif A and Doyle, Patrick S. 2022. "Hydrogel Microparticle‐Templated Anti‐Solvent Crystallization of Small‐Molecule Drugs." Advanced Healthcare Materials, 11 (8).
Version
Final published version
Abstract
Conventional formulation strategies for hydrophobic small‐molecule drug products frequently include mechanical milling to decrease active pharmaceutical ingredient (API) crystal size and subsequent granulation processes to produce an easily handled powder. A hydrogel‐templated anti‐solvent crystallization method is presented for the facile fabrication of microparticles containing dispersed nanocrystals of poorly soluble API. Direct crystallization within a porous hydrogel particle template yields core–shell structures in which the hydrogel core containing API nanocrystals is encased by a crystalline API shell. The process of controllable loading (up to 64% w/w) is demonstrated, and tailored dissolution profiles are achieved by simply altering the template particle size. API release is well described by a shrinking core model. Overall, the approach is a simple, scalable and potentially generalizable method that enables novel means of independently controlling both API crystallization and excipient characteristics, offering a “designer” drug particle system.
MIT Department
Massachusetts Institute of Technology. Department of Chemical Engineering
Terms of Use
Creative Commons Attribution-NonCommercial-NoDerivatives
https://creativecommons.org/licenses/by-nc-nd/4.0/
Persistent DSpace Link
https://hdl.handle.net/1721.1/158282
DOI of Published Version
https://doi.org/10.1002/adhm.202102252
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.